检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]苏州市相城人民医院消化科,江苏省苏州市215131 [2]苏州大学附属第二人民医院消化科,江苏省苏州市215004
出 处:《世界华人消化杂志》2014年第27期4210-4213,共4页World Chinese Journal of Digestology
摘 要:目的:探讨甘精胰岛素在肝源性糖尿病中的应用价值.方法:应用甘精胰岛素控制82例肝源性糖尿病患者的血糖,随后对其空腹血糖(fasting b l o o d g l u c o s e,F B G)、餐后2 h血糖(2 h postprandial blood glucose,2 h PBG)及低血糖发生等情况进行随访24 wk,每12 wk检测一次糖化血红蛋白(glycosylated hemoglobin,HbAlc),然后将治疗12、24 wk后的FBG、2 h PBG及HbAlc与治疗前比较.结果:治疗12 wk后FBG、2 h PBG及HbAlc均较治疗前明显下降(FBG:6.35 mmol/L±1.47 mmol/L vs 10.52 mmol/L±3.13 mmol/L,P<0.05;2 h PBG:9.81 mmol/L±3.14 mmol/L vs17.51 mmol/L±4.33 mmol/L,P<0.05;HbAlc:7.54%±1.31%vs 10.65%±1.43%,P<0.05),而治疗24 wk后血糖及HbAlc与治疗12 wk后相比无明显变化(FBG:6.47 mmol/L±1.25 mmol/L vs 6.35 mmol/L±1.47 mmol/L,P>0.05;2h PBG:8.91 mmol/L±2.76 mmol/L vs 9.81mmol/L±3.14 mmol/L,P>0.05;HbAlc:7.28%±1.12%vs 7.54%±1.31%,P>0.05),治疗期间低血糖发生率低,仅仅发生过一次.结论:甘精胰岛素对肝源性糖尿病的血糖控制安全有效.AIM: To assess the efficacy of glargine in the management of hepatogenic diabetes.METHODS: Eighty-two patients with hepa- togenic diabetes treated with glargine were included in the study. The insulin dose was adjusted according to fasting blood glucose (FBG) till discharge. FBG, 2 h postprandial blood glucose (2 h PBG) and glycosylated hemoglobin (HbAlc) were monitored for 24 wk. HbAlc and blood glucose levels were compared before and after treatment.RESULTS: The FBG, 2 h PBG and HbAlc were significantly decreased after treatment (FBG: 6.35 mmol/L ± 1.47 mmol/L vs 10.52 mmol/L ± 3.13mmol/L, P 〈 0.05; 2 h PBG: 9.81 mmol/L ± 3.14 mmol/L vs 17.51 mmol/L ±4.33 mmol/L, P 〈 0.05; HbAlc: 7.54% ± 1.31% vs 10.65% ± 1.43%, P 〈 0.05). There were no significant differences in the above parameters between 12 and 24 wk after treatment (FBG: 6.47 mmol/L ± 1.25 mmol/L vs 6.35 mmol/ L± 1.47 mmol/L, P 〉 0.05; 2 h PBG: 8.91 mmol/L ± 2.76 mmol/L vs 9.81 mmol/L ± 3.14 mmol/L, P 〉 0.05; HbAlc: 7.28% ±1.12% vs 7.54% ± 1.31%, P 〉 0.05). The incidence of hypoglycemia was low, which occurred only once:CONCLUSION: Glargine therapy is effective and safe for hepatogenic diabetes.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.148.108.240